logo-color
  • HOME
  • About
  • People
  • Process
  • Portfolio
  • News
  • Careers
  • Contact
Mobile Site Logo
  • HOME
  • About
  • People
  • Process
  • Portfolio
  • News
  • Careers
  • Contact

Archives

April 8, 2026

Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors

Press Release

March 27, 2025

Supira Medical CEO Interview with Joe Mullings at TCT 2024

Video

March 26, 2025

Supira Medical Secures $120M Oversubscribed Series E Financing and Completes Enrollment of SUPPORT I Early Feasibility Study in the United States

Press Release

November 21, 2024

Supira Medical Initiates U.S. Early Feasibility Study (EFS) for High-Risk PCI

Press Release

November 21, 2023

Supira Medical, Inc., a Shifamed Portfolio Company, Receives FDA Breakthrough Device Designation as the Company Closed $40M in Series D Financing

Press Release

October 20, 2023

Supira Medical’s Next Generation Percutaneous Ventricular Assist Device (pVAD) System to be Highlighted in a Live Case and Multiple Sessions at the Upcoming TCT 2023 Conference

Press Release

October 10, 2023

How Nitin Salunke’s different mindset helped him shift career from engineer to CEO of Supira Medical

Podcast

May 12, 2023

Supira Medical’s Percutaneous Ventricular Assist Device (pVAD) to be Highlighted During PCR Innovator’s Day and SCAI 2023

Press Release

March 7, 2023

Smaller, Faster, Better: New Developments in pVAD

Article

September 16, 2022

Supira Medical Announces Successful First-In-Human Use Of Its Next Generation Percutaneous Ventricular Assist Device

Press Release

  • « older posts
Link to top of page

© 2026 All Rights Reserved  Privacy Policy

Shifamed, LLC

590 Division Street

Campbell, CA 95008

info@shifamed.com

PHONE: +1 408.560.2500

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}